Reference range of rivaroxaban‐calibrated anti‐Xa activity in Chinese children with giant coronary artery aneurysms after KawasakI disease: insights from a population pharmacokinetic and pharmacodynamic analysis

Documenti analoghi

• Percutaneous intervention of a giant native coronary artery aneurysm using self‐expanding stents
  di: Abhishek Chaturvedi, et al.
  Pubblicazione: (2024)
• The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
  di: Yue Liu, et al.
  Pubblicazione: (2025)
• The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo
  di: Xiu Yan, et al.
  Pubblicazione: (2024)
• Extracellular vesicles as the next‐generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics
  di: Jiaqi Liu, et al.
  Pubblicazione: (2024)
• Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment
  di: Xiaoni Wang, et al.
  Pubblicazione: (2025)